Indefinite Delivery Contract SPE2DR25D1991

The federal contract IDV award SPE2DR25D1991 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, covers a broad range of pharmaceutical and medical supply products to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention.

The IDC serves as a prime vehicle for DLA to procure these critical medical commodities, with separate distribution fees for brand/generic and specialty pharmaceuticals to support both normal and contingency operations. The contract has a 30-month base period and three 30-month option periods, running through December 2036. This procurement was an unrestricted, fully competitive acquisition with the intent to make multiple regional awards, though Amerisourcebergen was the sole recipient of this particular IDC. The scope and value of this contract demonstrate Amerisourcebergen's position as a key supplier of pharmaceutical and medical products to various federal healthcare programs, particularly within the military.